Opportunity

Simpler Grants.gov #HT942526ALSRPCOBA

Army ALS Research Program Clinical Outcomes and Biomarkers Award Grant Opportunity

Buyer

U.S. Army Medical Research Acquisition Activity

Posted

May 04, 2026

Respond By

October 01, 2026

Identifier

HT942526ALSRPCOBA

NAICS

541715

The US Army Medical Research Acquisition Activity (USAMRAA) is seeking applications for the Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA): - Government Buyer: - Department of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Products/Services Requested: - Research projects focused on the development and validation of clinical outcomes and biomarkers for ALS - Eligible projects may include: - Identification, development, and validation of susceptibility/risk, diagnostic, monitoring/disease progression, prognostic, predictive, response, or safety biomarkers - Use of digital health measures (e.g., wearable devices, smartphone sensors, video/voice recordings, imaging studies, or other physiological data collection devices) - Community collaboration with the ALS lived experience community (required) - Unique/Notable Requirements: - Emphasis on digital health tools and innovative biomarker development - Mandatory collaboration with the ALS patient community - Open to domestic and foreign, for-profit and nonprofit organizations - Funding Details: - Approximately seven awards anticipated - Total available funding: $7,000,000 - No specific OEMs or vendors are named, as this is a research grant opportunity

Description

The FY26 Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects may focus on clinical biomarkers and/or clinical outcomes, including identification, development, and validation of biomarkers such as susceptibility/risk, diagnostic, monitoring/disease progression, prognostic, predictive, response, or safety biomarkers. The award encourages use of digital health measures and requires community collaboration with the ALS lived experience community. The program expects to fund approximately seven awards with a total funding amount of $7 million.

View original listing